Back to BlackRock, Inc. BlackRock, Inc.

PBYIPBYI
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in PUMA BIOTECHNOLOGY INC

BlackRock, Inc. holds 3.8M shares of PBYI (PUMA BIOTECHNOLOGY INC), worth $30.9M as of 2026-Q2. The position was increased (+5.7% shares). PBYI represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$30.9M

Current Shares

3.8M

Total Value Change

+$19.2M

Total Shares Change

-19,069

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.8M
+5.7%
$30.9M0.0%$8.11
31
2026-Q1
Decreased
3.6M
-1.2%
$23M0.0%$6.21
0
2025-Q4
Increased
3.6M
+1.8%
$21.7M0.0%$6.01
29
2025-Q3
Decreased
3.6M
-6.7%
$19M0.0%$5.05
0
2025-Q2
Decreased
3.8M
-0.3%
$13.2M0.0%$3.33
0
2025-Q1
Increased
3.8M
+0.6%
$11.4M0.0%$3.14
28
2024-Q4
New
3.8M
-
$11.7M0.0%$3.13
39

Other major holders of PBYI: BLACKROCK ADVISORS LLC, FEDERATED HERMES, INC., BNP PARIBAS FINANCIAL MARKETS, FRED ALGER MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used